CAMPIERI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 7.619
EU - Europa 4.905
AS - Asia 2.756
AF - Africa 367
SA - Sud America 14
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.670
Nazione #
US - Stati Uniti d'America 7.542
GB - Regno Unito 1.266
CN - Cina 863
SE - Svezia 821
IT - Italia 777
SG - Singapore 741
VN - Vietnam 706
DE - Germania 623
IE - Irlanda 291
UA - Ucraina 288
IN - India 247
RU - Federazione Russa 190
FR - Francia 187
TG - Togo 139
BG - Bulgaria 100
ZA - Sudafrica 95
CH - Svizzera 94
JO - Giordania 91
CI - Costa d'Avorio 84
EE - Estonia 84
BE - Belgio 57
FI - Finlandia 42
HN - Honduras 36
JP - Giappone 28
CA - Canada 25
SC - Seychelles 25
NG - Nigeria 23
IR - Iran 20
NL - Olanda 19
GR - Grecia 17
BZ - Belize 15
HK - Hong Kong 12
ES - Italia 10
CL - Cile 8
PL - Polonia 8
AU - Australia 7
HR - Croazia 7
ID - Indonesia 7
RO - Romania 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
PT - Portogallo 6
KR - Corea 5
MY - Malesia 5
UZ - Uzbekistan 5
PH - Filippine 4
BR - Brasile 3
PK - Pakistan 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
IL - Israele 2
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
PE - Perù 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 15.670
Città #
Southend 1.110
Chandler 806
Fairfield 763
Ashburn 664
Singapore 646
Santa Clara 459
Dong Ket 421
Woodbridge 411
Princeton 348
Houston 345
Seattle 330
Wilmington 329
Ann Arbor 291
Dublin 291
Cambridge 273
Boardman 180
Jacksonville 165
Lomé 139
Bologna 131
Berlin 127
Nanjing 119
Westminster 114
Padova 104
Sofia 96
Amman 91
Abidjan 84
Milan 80
Bern 79
San Diego 75
Beijing 71
Shenyang 59
New York 55
Saint Petersburg 52
Turin 52
Hebei 43
Changsha 41
Jinan 41
Nanchang 40
Helsinki 39
Phoenix 39
Mülheim 38
Bremen 34
Brussels 34
Guangzhou 34
Henderson 34
Redwood City 34
Medford 33
Washington 29
Centro 26
Rome 26
Saint Louis 26
Los Angeles 24
Tianjin 24
Dearborn 23
Olalla 23
Redmond 23
Brierley Hill 21
Haikou 20
Jiaxing 20
Mahé 19
Shanghai 19
Taizhou 19
Abeokuta 17
Norwalk 17
Toronto 17
Falls Church 16
Florence 16
Tokyo 16
Zhengzhou 16
Atlanta 15
Belize City 15
Cervia 14
Chicago 14
Frankfurt am Main 14
Pune 14
Taiyuan 13
Hangzhou 12
Leawood 12
Ningbo 12
Des Moines 11
Kunming 11
Paris 11
San Venanzo 10
Wuhan 10
Buffalo 9
Columbus 9
Fremont 9
Provo 9
San Pedro Sula 9
Verona 9
Zwijnaarde 9
Andover 8
Bühl 8
Fuzhou 8
Lanzhou 8
Mantova 8
Monmouth Junction 8
Chengdu 7
Falkenstein 7
Frankfurt Am Main 7
Totale 10.621
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 520
Ulcerative Colitis 218
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 213
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 210
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 188
Adult attachment and early parental experiences in patients with Crohn’s Disease 182
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 164
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 161
Infliximab in the treatment of Crohn's disease 161
Attachment and quality of life in patients with inflammatory bowel disease 161
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study 160
null 159
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 159
Attachment and perceived stress in patients with ulcerative colitis, a case–control study 158
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 156
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 155
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 155
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 154
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 154
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 149
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 147
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 147
Clinical course of microscopic colitis in a single-center cohort study 146
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 142
High-dose probiotics for the treatment of active pouchitis 142
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 142
Management and treatment of distal ulcerative colitis 142
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 141
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 139
Alessitimia e stress percepito in 323 pazienti affetti da IBD 136
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 136
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 135
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 134
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 133
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 132
Oral budesonide in the treatment of chronic refractory pouchitis. 131
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 131
Attachment and mentalizing abilities in patients with inflammatory bowel disease 130
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx 129
Medical treatment and management of severe ulcerative colitis 128
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 128
Sympathetic hyperactivity in patients with ulcerative colitis. 127
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 127
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 127
Antibiotics and probiotics in treatment of inflammatory bowel disease 127
Antimicrobials in the management of inflammatory bowel disease 126
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 126
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 124
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 122
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 122
The role of Budesonide-MMX in active ulcerative colitis. 122
Review article: aminosalicylates for distal colitis 121
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 121
MANAGEMENT OF POUCHITIS 120
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 119
Randomized controlled trials in pouchitis 119
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 119
Which therapies are advisable in pouchitis? 118
Oral beclomethasone dipropionate in chronic refractory pouchitis 118
Role of conventional therapies in the era of biological treatment in Crohn's disease. 118
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 116
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin 115
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 115
Problematic proctitis and distal colitis 114
Parental Bonding and Inflammatory Bowel Disease 112
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 112
Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: Implications in colonic pathophysiology 112
Probiotic therapy to prevent pouchitis onset 111
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 111
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 111
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 110
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 109
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 108
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 107
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials 107
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 107
Management of inflammatory bowel disease: does rifaximin offer any promises 104
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 103
M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis 101
The role of antibiotics and probiotics in pouchitis 101
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 101
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 99
Probiotics and barrier function in colitis 98
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 97
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 97
TREATMENT OF PERIANAL CROHN'S DISEASE WITH COMBINED SURGICAL AND BIOLOGICAL THERAPY 95
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 95
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 94
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. 94
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 90
VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics 90
Depressione e dolore viscerale nel paziente con IBD. 89
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue 89
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 89
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 86
null 86
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. 85
null 84
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 83
null 83
Totale 12.941
Categoria #
all - tutte 45.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.803 0 0 0 0 0 0 398 416 442 248 119 180
2020/20212.351 385 125 42 111 70 142 101 200 194 192 81 708
2021/20222.895 307 68 172 138 213 106 65 124 262 228 806 406
2022/20233.471 379 509 198 413 198 294 82 199 666 81 229 223
2023/2024989 69 147 92 77 98 272 46 51 21 61 27 28
2024/20252.012 176 490 291 218 649 158 30 0 0 0 0 0
Totale 16.228